Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity (Q38074340)

28 August 2017

1 reference

title

Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity (English)

1 reference

28 August 2017

1 reference

Dominic J Hare

1

1 reference

28 August 2017

Paul A Adlard

series ordinal

2

1 reference

28 August 2017

Philip A Doble

series ordinal

3

1 reference

28 August 2017

David I Finkelstein

series ordinal

4

1 reference

28 August 2017

1 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

5

1 reference

28 August 2017

2

1 reference

28 August 2017

91-109

1 reference

Epidemiology of Parkinson's disease

28 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

An Essay on the Shaking Palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Altered systemic iron metabolism in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Microglia activation is related to substantia nigra echogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Transcranial sonography in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Protocol for the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Oxidative stress in neurodegeneration: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Manganese mimics the action of 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in rat striatal tissue slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Manganese does not alter the severe neurotoxicity of MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper, Zinc, and the Metallobiology of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper, oxidative stress, and human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper ions disrupt dopamine metabolism via inhibition of V-H+-ATPase: a possible contributing factor to neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper complexes as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The role of alpha-synuclein in Parkinson's disease: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The possible role of iron in the etiopathology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

ParkDB: a Parkinson's disease gene expression database

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Dopamine efflux by MPTP and hydroxyl radical generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Oxidative damage to ferritin by 5-aminolevulinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

A nuclear microscopic and histochemical study of iron concentrations and distribution in the midbrain of two age groups of monkeys unilaterally injected with MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Role of dietary iron restriction in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Protective effects of heme oxygenase-1 against MPP(+)-induced cytotoxicity in PC-12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The role of tau in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron trafficking inside the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The metabolism of neuronal iron and its pathogenic role in neurological disease: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

VTA neurons show a potentially protective transcriptional response to MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron metabolism in Parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Oxidative stress and brain aging: is zinc the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Zinc in the physiology and pathology of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The antioxidant properties of zinc and metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Expression and regulation of brain metallothionein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Metals in our minds: therapeutic implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotective actions of selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Apomorphine protects against MPTP-induced neurotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

A 6-hydroxydopamine-induced selective parkinsonian rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Iron accumulation in the substantia nigra in rats visualized by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper-triggered aggregation of ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodie

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Copper Resistance and Accumulation in the Zygomycete Mucor rouxii

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Changes of metallothionein i + ii proteins in the brain after l-methyl-4-phenylpyridinium administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

Quantitative elemental bio-imaging of Mn, Fe, Cu and Zn in 6-hydroxydopamine induced Parkinsonism mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20164J

21 January 2018

Identifiers

DOI

10.1039/C2MT20164J

1 reference

28 August 2017

1 reference